Justification
Peramivir (RAPIVAB (peramivir injection)
75A50324F80012-LSJ
Office of Assistant Secretary for Preparedness and Response, Aspr/Orm-Sns. Pharmaceutical Preparation Manufacturing.
Awarded
$0.00 obligated so far on USAspending, September 25, 2024, contract 36F79721D0166
Description
As published on SAM.gov.
Peramivir (RAPIVAB (peramivir injection) 200mg/20ml vials (10mg/ml inj soln)); NDC 72769-0181-03.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Biocryst Pharmaceuticals Inc.
- UEI
- MGXADJ6SCLJ5
- CAGE
- 4GBX7
- Vendor location
- Durham, NC
- Contract
- 36F79721D0166
- Obligated
- $0.00, potential $1,250,000
- Actions
- 5 between November 21, 2024 and August 31, 2026
- Competition
- Full and Open Competition, 999 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- Public Law 2025
- Match
- award number 36F79721D0166 equals the contract number; awarding office not confirmed (medium confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
September 25, 2024
Justification, originally award notice
SAM.gov, notice e72663d9d693488186b60e08650d980b
Points of contact
- Terri Reedterri.reed@hhs.gov
Also open from this buyer
- SNS Pharmaceutical Logistic Replenishment RequirementCombined synopsis and solicitationNAICS 325412New York75A50326R00007Closes todaySep 18